000 | 01007 a2200289 4500 | ||
---|---|---|---|
005 | 20250515191827.0 | ||
264 | 0 | _c20091130 | |
008 | 200911s 0 0 eng d | ||
022 | _a1527-3792 | ||
024 | 7 |
_a10.1016/j.juro.2009.08.193 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSinger, Frederick R | |
245 | 0 | 0 |
_aEditorial comment. _h[electronic resource] |
260 |
_bThe Journal of urology _cDec 2009 |
||
300 |
_a2676; dscussion 2676 p. _bdigital |
||
500 | _aPublication Type: Comment; Journal Article | ||
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 | _aDenosumab |
650 | 0 | 4 |
_aFractures, Bone _xetiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aProstatic Neoplasms _xtherapy |
650 | 0 | 4 |
_aRANK Ligand _xtherapeutic use |
773 | 0 |
_tThe Journal of urology _gvol. 182 _gno. 6 _gp. 2676; dscussion 2676 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.juro.2009.08.193 _zAvailable from publisher's website |
999 |
_c19228764 _d19228764 |